Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2025 Earnings Call Transcript May 12, 2025
Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2.75, expectations were $-0.06.
– :
Operator: Ladies and gentlemen, welcome to the Arrow Pharmaceuticals Conference Call. Throughout today’s recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference over to...
